|
12 Companies |
|
14 Products |
|
14 Products |
|
13 Mechanisms of Action |
|
1 Trial |
|
203 News |
|
| «12345» |
- Trial completion, Trial primary completion date: CATS: Transdisciplinary Studies of CBT for Anxiety in Youth: Child Anxiety Treatment Study (clinicaltrials.gov) - Jul 18, 2014
P=N/A, N=194, Completed, Sponsor: University of Pittsburgh
Recruiting --> Completed | Trial primary completion date: Aug 2013 --> Jul 2014
- ||| paroxetine / Generic mfg.
Trial completion: Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term) (clinicaltrials.gov) - Jul 2, 2014
P=N/A, N=600, Completed, Sponsor: GlaxoSmithKline
Recruiting --> Completed | Trial primary completion date: Aug 2013 --> Jul 2014 Active, not recruiting --> Completed
- Trial primary completion date: Attention Bias Modification Treatment for Children With Social Anxiety (clinicaltrials.gov) - Jun 18, 2014
P2, N=70, Recruiting, Sponsor: Tel Aviv University
Active, not recruiting --> Completed Trial primary completion date: Dec 2013 --> Aug 2014
- Enrollment change, Trial primary completion date: Attention Bias Modification Treatment for Children With Social Anxiety (clinicaltrials.gov) - Jun 18, 2014
P2, N=70, Recruiting, Sponsor: Tel Aviv University
Trial primary completion date: Dec 2013 --> Aug 2014 N=120 --> 70 | Trial primary completion date: Dec 2013 --> Aug 2014
- | duloxetine / Generic mfg.
Trial completion: Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome (clinicaltrials.gov) - Jun 8, 2014
P3, N=28, Completed, Sponsor: Massachusetts General Hospital
N=120 --> 70 | Trial primary completion date: Dec 2013 --> Aug 2014 Active, not recruiting --> Completed
- Trial primary completion date: Efficacy of a Mindfulness Meditation Program for Social Anxiety Disorder (clinicaltrials.gov) - May 8, 2014
P=N/A, N=40, Recruiting, Sponsor: Hopital Montfort
Active, not recruiting --> Completed Trial primary completion date: Aug 2014 --> Dec 2014
- Trial completion date: Efficacy of a Mindfulness Meditation Program for Social Anxiety Disorder (clinicaltrials.gov) - May 8, 2014
P=N/A, N=40, Recruiting, Sponsor: Hopital Montfort
Trial primary completion date: Aug 2014 --> Dec 2014 Trial completion date: Dec 2014 --> Mar 2015
- Enrollment change: Efficacy of a Mindfulness Meditation Program for Social Anxiety Disorder (clinicaltrials.gov) - May 8, 2014
P=N/A, N=40, Recruiting, Sponsor: Hopital Montfort
Trial completion date: Dec 2014 --> Mar 2015 N=32 --> 40
- Trial completion: A Research Study of How Teens With and Without an Anxiety Disorder Make Decisions (clinicaltrials.gov) - Apr 14, 2014
P1, N=127, Completed, Sponsor: New York University School of Medicine
N=32 --> 40 Recruiting --> Completed
- Trial completion: Effectiveness of Cognitive Behavioral Therapy (CBT) for Child Anxiety Disorders in Community Clinics in Norway (clinicaltrials.gov) - Apr 10, 2014
P2, N=165, Completed, Sponsor: Regionsenter for barn og unges psykiske helse
Recruiting --> Completed Recruiting --> Completed
- Enrollment change: Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning (clinicaltrials.gov) - Apr 9, 2014
P=N/A, N=508, Recruiting, Sponsor: National Institute of Mental Health (NIMH)
Recruiting --> Completed N=404 --> 508
- || New P3 trial: TAASD: Psychotherapy for Anxiety in Children With Autism Spectrum Disorder (clinicaltrials.gov) - Apr 9, 2014
P3, N=201, Recruiting, Sponsor: Temple University
- ||| Synera (lidocaine 70 mg/tetracaine 70 mg/heated Topical Patch) / Miravo, Eurocept, Galen, Samaritan Pharma
Trial initiation date: Effect of Including Synera (clinicaltrials.gov) - Apr 3, 2014
P4, N=64, Recruiting, Sponsor: Davita Clinical Research
N=404 --> 508 Initiation date: Jan 2013 --> Apr 2014
- |||| Synera (lidocaine 70 mg/tetracaine 70 mg/heated Topical Patch) / Miravo, Eurocept, Galen, Samaritan Pharma
Enrollment open: Effect of Including Synera (clinicaltrials.gov) - Apr 3, 2014
P4, N=64, Recruiting, Sponsor: Davita Clinical Research
Initiation date: Jan 2013 --> Apr 2014 Not yet recruiting --> Recruiting
- Enrollment closed: Internet-delivered Psychodynamic Therapy for Social Anxiety Disorder (SOFIA) (clinicaltrials.gov) - Apr 3, 2014
P=N/A, N=72, Active, not recruiting, Sponsor: Linkoeping University
Not yet recruiting --> Recruiting Not yet recruiting --> Active, not recruiting
- Enrollment change: SP Interp: Interpretation Modification Program for Social Phobia (clinicaltrials.gov) - Apr 1, 2014
P=N/A, N=49, Completed, Sponsor: San Diego State University
Not yet recruiting --> Active, not recruiting N=72 --> 49
- Enrollment change: SPAttn: Attention Disengagement Training for Social Phobia (clinicaltrials.gov) - Apr 1, 2014
P=N/A, N=48, Completed, Sponsor: San Diego State University
N=72 --> 49 N=72 --> 48
- Trial completion: SP Interp: Interpretation Modification Program for Social Phobia (clinicaltrials.gov) - Apr 1, 2014
P=N/A, N=49, Completed, Sponsor: San Diego State University
N=72 --> 48 Recruiting --> Completed
- Trial completion: SPAttn: Attention Disengagement Training for Social Phobia (clinicaltrials.gov) - Apr 1, 2014
P=N/A, N=48, Completed, Sponsor: San Diego State University
Recruiting --> Completed Recruiting --> Completed
- Enrollment change: Variations of Cognitive Behavior Therapy for Social Anxiety Disorder (clinicaltrials.gov) - Mar 26, 2014
P=N/A, N=120, Recruiting, Sponsor: Drexel University
Recruiting --> Completed N=80 --> 120
- Enrollment open: Variations of Cognitive Behavior Therapy for Social Anxiety Disorder (clinicaltrials.gov) - Mar 26, 2014
P=N/A, N=120, Recruiting, Sponsor: Drexel University
N=80 --> 120 Not yet recruiting --> Recruiting
- Clinical: Cognitive Behavioural Treatment of Intra-oral Injection-phobia in 10-16 Year Old Children and Adolescents (clinicaltrials.gov) - Mar 9, 2014
P=N/A, N=60, Enrolling by invitation, Sponsor: University of Bergen
- Clinical: False Safety Behavior Elimination Therapy: A Randomized Study of a Brief Individual Transdiagnostic Treatment for Anxiety Disorders (clinicaltrials.gov) - Mar 6, 2014
P=N/A, N=28, Completed, Sponsor: Florida State University
- | NN1213 / Novo Nordisk
Trial completion: St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD) (clinicaltrials.gov) - Feb 22, 2014
P2/3, N=56, Completed, Sponsor: National Center for Complementary and Alternative Medicine (NCCAM)
Not yet recruiting --> Recruiting Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Assessment and Treatment of Social Skills Deficits in Individuals With Social Phobia (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=379, Completed, Sponsor: Milton S. Hershey Medical Center
Recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Treatment for Specific Phobias in Children (clinicaltrials.gov) - Feb 22, 2014
P1/2, N=150, Completed, Sponsor: Virginia Polytechnic Institute and State University
Active, not recruiting --> Completed Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Treatment of Childhood Social Phobia (clinicaltrials.gov) - Feb 22, 2014
P3, N=139, Completed, Sponsor: University of Central Florida
Recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Treatment of Youth With ADHD and Anxiety (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=120, Completed, Sponsor: National Institute of Mental Health (NIMH)
No longer recruiting --> Completed No longer recruiting --> Completed
- | New P1/2 trial: Brief Behavioral Treatment for Anxiety in Young Children (clinicaltrials.gov) - Jan 29, 2014
P1/2, N=60, Recruiting, Sponsor: University of South Florida
- Enrollment open: Brief Behavioral Treatment for Anxiety in Young Children (clinicaltrials.gov) - Jan 28, 2014
P1/2, N=60, Recruiting, Sponsor: University of South Florida
No longer recruiting --> Completed Not yet recruiting --> Recruiting
- |||| desvenlafaxine extended release / Generic mfg.
Trial completion: 12-Week Study of Pristiq (Desvenlafaxine) Social Anxiety Disorder (clinicaltrials.gov) - Jan 15, 2014
P4, N=63, Completed, Sponsor: The Medical Research Network
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Enrollment closed: Emotion Regulation During RCT of CBT vs. MBSR for Social Anxiety Disorder (clinicaltrials.gov) - Jan 13, 2014
P=N/A, N=108, Active, not recruiting, Sponsor: Stanford University
Active, not recruiting --> Completed Not yet recruiting --> Active, not recruiting
- Enrollment closed: Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism (clinicaltrials.gov) - Jan 1, 2014
P=N/A, N=50, Active, not recruiting, Sponsor: University of South Florida
Not yet recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- || propranolol / Generic mfg.
New P2/3 trial: Noradrenergic Manipulation and Virtual Reality Exposure Therapy in Phobic Participants (clinicaltrials.gov) - Dec 9, 2013
P2/3, N=60, Recruiting, Sponsor: VU University of Amsterdam
- Trial completion: D-cycloserine and Treatment of Feeding Disorders (clinicaltrials.gov) - Dec 9, 2013
P1/2, N=16, Completed, Sponsor: Emory University
Recruiting --> Active, not recruiting Recruiting --> Completed
- | quetiapine extended-release / Generic mfg.
Enrollment change: Flushing in Social Anxiety Disorder on Seroquel (clinicaltrials.gov) - Oct 28, 2013
P3, N=21, Completed, Sponsor: START Clinic for Mood and Anxiety Disorders
Recruiting --> Completed N=44 --> 21
- Enrollment change: OMEGA3SP: An Open Label Trial of Omega 3(o3mega+Joy)in the Treatment of Social Phobia (clinicaltrials.gov) - Oct 28, 2013
P2, N=8, Completed, Sponsor: START Clinic for Mood and Anxiety Disorders
N=44 --> 21 N=50 --> 8
- || quetiapine extended-release / Generic mfg.
Trial completion: Flushing in Social Anxiety Disorder on Seroquel (clinicaltrials.gov) - Oct 28, 2013
P3, N=21, Completed, Sponsor: START Clinic for Mood and Anxiety Disorders
N=50 --> 8 Active, not recruiting --> Completed
- |||| citalopram / Generic mfg., escitalopram / Generic mfg.
Trial completion: Flushing in Social Anxiety Disorder on Cipralex (clinicaltrials.gov) - Oct 28, 2013
P2, N=71, Completed, Sponsor: START Clinic for Mood and Anxiety Disorders
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: OMEGA3SP: An Open Label Trial of Omega 3(o3mega+Joy)in the Treatment of Social Phobia (clinicaltrials.gov) - Oct 28, 2013
P2, N=8, Completed, Sponsor: START Clinic for Mood and Anxiety Disorders
Active, not recruiting --> Completed Recruiting --> Completed
- epinephrine / Generic mfg.
Trial completion: Comparative Study of Autologous Blood Injection Versus Diluted Epinephrine in Treating Actively Bleeding Gastroduodenal Ulcers (clinicaltrials.gov) - Sep 23, 2013
P=N/A, N=100, Completed, Sponsor: Zagazig University
Recruiting --> Completed Recruiting --> Completed
- Enrollment change: Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety (clinicaltrials.gov) - Sep 5, 2013
P3, N=40, Completed, Sponsor: Southern Methodist University
Recruiting --> Completed N=30 --> 40
- Trial completion: Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety (clinicaltrials.gov) - Sep 5, 2013
P3, N=40, Completed, Sponsor: Southern Methodist University
N=30 --> 40 Recruiting --> Completed
- Enrollment open: Substance-focused SBI as a Complement to Internet-based Psychiatric Treatment: RCT (clinicaltrials.gov) - Sep 3, 2013
P=N/A, N=124, Recruiting, Sponsor: Karolinska Institutet
Recruiting --> Completed Not yet recruiting --> Recruiting
- epinephrine / Generic mfg.
Enrollment change: Comparative Study of Autologous Blood Injection Versus Diluted Epinephrine in Treating Actively Bleeding Gastroduodenal Ulcers (clinicaltrials.gov) - Sep 1, 2013
P=N/A, N=100, Completed, Sponsor: Zagazig University
Not yet recruiting --> Recruiting N=50 --> 100
- Enrollment closed: Intervention for Anxiety After Falls (clinicaltrials.gov) - Aug 18, 2013
P1, N=32, Active, not recruiting, Sponsor: Weill Medical College of Cornell University
N=50 --> 100 Recruiting --> Active, not recruiting
- New P1/2 trial: D-cycloserine and Treatment of Feeding Disorders (clinicaltrials.gov) - Aug 14, 2013
P1/2, N=16, Completed, Sponsor: Emory University
- quetiapine extended-release / Generic mfg.
Enrollment closed: Quetiapine in Co-Morbid Depressive and Anxiety Disorders (clinicaltrials.gov) - Aug 14, 2013
P=N/A, N=105, Active, not recruiting, Sponsor: Centre for Addiction and Mental Health
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | fluoxetine / Generic mfg.
Enrollment change: Treatment of Childhood Social Phobia (clinicaltrials.gov) - Jul 30, 2013
P3, N=139, Completed, Sponsor: University of Central Florida
Recruiting --> Active, not recruiting N=250 --> 139
- Enrollment open: Retraining Attention to Treat Alcohol Dependence and Social Anxiety (clinicaltrials.gov) - Jul 14, 2013
P=N/A, N=68, Recruiting, Sponsor: University of Cincinnati
N=250 --> 139 Not yet recruiting --> Recruiting